V
MRNA icon

Veritable’s Moderna MRNA Stock Holding History

Veritable’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,205
Closed -$632K – 514
2023
Q2 		$632K Sell
5,205
-644
-11% -$85.9K 0.01% 480
2023
Q1 		$898K Sell
5,849
-102
-2% -$16.8K 0.02% 395
2022
Q4 		$1.07M Sell
5,951
-1,159
-16% -$190K 0.02% 341
2022
Q3 		$841K Buy
7,110
+1,781
+33% +$270K 0.02% 385
2022
Q2 		$761K Buy
5,329
+494
+10% +$70.6K 0.01% 437
2022
Q1 		$833K Buy
4,835
+1,196
+33% +$201K 0.01% 435
2021
Q4 		$924K Sell
3,639
-977
-21% -$286K 0.01% 418
2021
Q3 		$1.78M Buy
4,616
+2,073
+82% +$765K 0.03% 264
2021
Q2 		$598K Buy
2,543
+624
+33% +$112K 0.01% 498
2021
Q1 		$251K Buy
+1,919
New +$278K ﹤0.01% 712

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return